BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28465103)

  • 1. Benzoxazolinone aryl sulfonamides as potent, selective Na
    Pero JE; Rossi MA; Lehman HDGF; Kelly MJ; Mulhearn JJ; Wolkenberg SE; Cato MJ; Clements MK; Daley CJ; Filzen T; Finger EN; Gregan Y; Henze DA; Jovanovska A; Klein R; Kraus RL; Li Y; Liang A; Majercak JM; Panigel J; Urban MO; Wang J; Wang YH; Houghton AK; Layton ME
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2683-2688. PubMed ID: 28465103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.
    Wang JT; Zheng YM; Chen YT; Gu M; Gao ZB; Nan FJ
    Acta Pharmacol Sin; 2020 Mar; 41(3):293-302. PubMed ID: 31316182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
    Roecker AJ; Egbertson M; Jones KLG; Gomez R; Kraus RL; Li Y; Koser AJ; Urban MO; Klein R; Clements M; Panigel J; Daley C; Wang J; Finger EN; Majercak J; Santarelli V; Gregan I; Cato M; Filzen T; Jovanovska A; Wang YH; Wang D; Joyce LA; Sherer EC; Peng X; Wang X; Sun H; Coleman PJ; Houghton AK; Layton ME
    Bioorg Med Chem Lett; 2017 May; 27(10):2087-2093. PubMed ID: 28389149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonamides as Selective Na
    Graceffa RF; Boezio AA; Able J; Altmann S; Berry LM; Boezio C; Butler JR; Chu-Moyer M; Cooke M; DiMauro EF; Dineen TA; Feric Bojic E; Foti RS; Fremeau RT; Guzman-Perez A; Gao H; Gunaydin H; Huang H; Huang L; Ilch C; Jarosh M; Kornecook T; Kreiman CR; La DS; Ligutti J; Milgram BC; Lin MJ; Marx IE; Nguyen HN; Peterson EA; Rescourio G; Roberts J; Schenkel L; Shimanovich R; Sparling BA; Stellwagen J; Taborn K; Vaida KR; Wang J; Yeoman J; Yu V; Zhu D; Moyer BD; Weiss MM
    J Med Chem; 2017 Jul; 60(14):5990-6017. PubMed ID: 28324649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
    Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
    Sun S; Jia Q; Zenova AY; Wilson MS; Chowdhury S; Focken T; Li J; Decker S; Grimwood ME; Andrez JC; Hemeon I; Sheng T; Chen CA; White A; Hackos DH; Deng L; Bankar G; Khakh K; Chang E; Kwan R; Lin S; Nelkenbrecher K; Sellers BD; DiPasquale AG; Chang J; Pang J; Sojo L; Lindgren A; Waldbrook M; Xie Z; Young C; Johnson JP; Robinette CL; Cohen CJ; Safina BS; Sutherlin DP; Ortwine DF; Dehnhardt CM
    J Med Chem; 2019 Jan; 62(2):908-927. PubMed ID: 30499663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of morpholine-based aryl sulfonamides as Na
    Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
    Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa
    Focken T; Chowdhury S; Zenova A; Grimwood ME; Chabot C; Sheng T; Hemeon I; Decker SM; Wilson M; Bichler P; Jia Q; Sun S; Young C; Lin S; Goodchild SJ; Shuart NG; Chang E; Xie Z; Li B; Khakh K; Bankar G; Waldbrook M; Kwan R; Nelkenbrecher K; Karimi Tari P; Chahal N; Sojo L; Robinette CL; White AD; Chen CA; Zhang Y; Pang J; Chang JH; Hackos DH; Johnson JP; Cohen CJ; Ortwine DF; Sutherlin DP; Dehnhardt CM; Safina BS
    J Med Chem; 2018 Jun; 61(11):4810-4831. PubMed ID: 29737846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of Na
    Boezio AA; Andrews K; Boezio C; Chu-Moyer M; Copeland KW; DiMauro EF; Foti RS; Fremeau RT; Gao H; Geuns-Meyer S; Graceffa RF; Gunaydin H; Huang H; La DS; Ligutti J; Moyer BD; Peterson EA; Yu V; Weiss MM
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2103-2108. PubMed ID: 29709252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of non-zwitterionic aryl sulfonamides as Na
    Wu YJ; Guernon J; McClure A; Luo G; Rajamani R; Ng A; Easton A; Newton A; Bourin C; Parker D; Mosure K; Barnaby O; Soars MG; Knox RJ; Matchett M; Pieschl R; Herrington J; Chen P; Sivarao DV; Bristow LJ; Meanwell NA; Bronson J; Olson R; Thompson LA; Dzierba C
    Bioorg Med Chem; 2017 Oct; 25(20):5490-5505. PubMed ID: 28818462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of benzoxazine sulfonamide inhibitors of Na
    La DS; Peterson EA; Bode C; Boezio AA; Bregman H; Chu-Moyer MY; Coats J; DiMauro EF; Dineen TA; Du B; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Fremeau R; Huang X; Ilch C; Kornecook TJ; Kreiman C; Ligutti J; Jasmine Lin MH; McDermott JS; Marx I; Matson DJ; McDonough SI; Moyer BD; Nho Nguyen H; Taborn K; Yu V; Weiss MM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3477-3485. PubMed ID: 28629594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Potent, Selective, and State-Dependent Na
    Ramdas V; Talwar R; Kanoje V; Loriya RM; Banerjee M; Patil P; Joshi AA; Datrange L; Das AK; Walke DS; Kalhapure V; Khan T; Gote G; Dhayagude U; Deshpande S; Shaikh J; Chaure G; Pal RR; Parkale S; Suravase S; Bhoskar S; Gupta RV; Kalia A; Yeshodharan R; Azhar M; Daler J; Mali V; Sharma G; Kishore A; Vyawahare R; Agarwal G; Pareek H; Budhe S; Nayak A; Warude D; Gupta PK; Joshi P; Joshi S; Darekar S; Pandey D; Wagh A; Nigade PB; Mehta M; Patil V; Modi D; Pawar S; Verma M; Singh M; Das S; Gundu J; Nemmani K; Bock MG; Sharma S; Bakhle D; Kamboj RK; Palle VP
    J Med Chem; 2020 Jun; 63(11):6107-6133. PubMed ID: 32368909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na
    McKerrall SJ; Nguyen T; Lai KW; Bergeron P; Deng L; DiPasquale A; Chang JH; Chen J; Chernov-Rogan T; Hackos DH; Maher J; Ortwine DF; Pang J; Payandeh J; Proctor WR; Shields SD; Vogt J; Ji P; Liu W; Ballini E; Schumann L; Tarozzo G; Bankar G; Chowdhury S; Hasan A; Johnson JP; Khakh K; Lin S; Cohen CJ; Dehnhardt CM; Safina BS; Sutherlin DP
    J Med Chem; 2019 Apr; 62(8):4091-4109. PubMed ID: 30943032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
    Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
    J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na
    McKerrall SJ; Sutherlin DP
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of New Benzenesulfonamides As Potent and Selective Na
    Wu YJ; Guernon J; Shi J; Ditta J; Robbins KJ; Rajamani R; Easton A; Newton A; Bourin C; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
    J Med Chem; 2017 Mar; 60(6):2513-2525. PubMed ID: 28234467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling.
    Kong DJ; Wang Y; Wang HX; Wang MX; Wang J; Cheng MS
    Comput Biol Chem; 2019 Dec; 83():107132. PubMed ID: 31563636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a biarylamide series of potent, state-dependent Na
    Schenkel LB; DiMauro EF; Nguyen HN; Chakka N; Du B; Foti RS; Guzman-Perez A; Jarosh M; La DS; Ligutti J; Milgram BC; Moyer BD; Peterson EA; Roberts J; Yu VL; Weiss MM
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3817-3824. PubMed ID: 28684121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of acyl sulfonamide derivatives with spiro cycles as Na
    Ouyang X; Su M; Xue D; Dong L; Niu H; Li W; Liu Y; Wang K; Shao L
    Bioorg Med Chem; 2023 May; 86():117290. PubMed ID: 37137269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.